Authors: SCHABER G STEVENS I GAERTNER HJ DIETZ K BREYERPFAFF U

Citation: G. Schaber et al., PHARMACOKINETICS OF CLOZAPINE AND ITS METABOLITES IN PSYCHIATRIC-PATIENTS - PLASMA-PROTEIN BINDING AND RENAL CLEARANCE, British journal of clinical pharmacology, 46(5), 1998, pp. 453-459

Authors: STEVENS I GAERTNER HJ

Citation: I. Stevens et Hj. Gaertner, ADVERSE EVENT RECORDING IN NEW ANTIDEPRES SANTS, Nervenheilkunde, 15(2), 1996, pp. 85-91

Authors: STEVENS I GAERTNER HJ

Citation: I. Stevens et Hj. Gaertner, PLASMA-LEVEL MEASUREMENT IN A PATIENT WITH CLOZAPINE INTOXICATION, Journal of clinical psychopharmacology, 16(1), 1996, pp. 86-87

Authors: BREYERPFAFF U WIATR G STEVENS I GAERTNER HJ MUNDLE G MANN K

Citation: U. Breyerpfaff et al., ELEVATED NORHARMAN PLASMA-LEVELS IN ALCOHOLIC PATIENTS AND CONTROLS RESULTING FROM TOBACCO SMOKING, Life sciences, 58(17), 1996, pp. 1425-1432

Authors: BREYERPFAFF U ENTENMANN A GAERTNER HJ

Citation: U. Breyerpfaff et al., SECRETION OF AMITRIPTYLINE AND METABOLITES INTO BREAST-MILK, The American journal of psychiatry, 152(5), 1995, pp. 812-813

Authors: STEVENS I GAERTNER HJ

Citation: I. Stevens et Hj. Gaertner, THERAPY WITH CLOZAPINE, Nervenheilkunde, 11(2), 1992, pp. 91-98